Search results for "acute rejection"

showing 2 items of 2 documents

Hepatocellular carcinoma recurrence after acute liver allograft rejection treatment: A multicenter European experience

2019

During the last decades, several risk factors for the recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT) have been investigated. However, the impact of two important drivers of oncogenesis, namely the immunosuppression and the treatment of acute cellular rejection (ACR) have been marginally addressed. This study aimed at investigating the impact of ACR treatment on the incidence of tumor recurrence in a large European HCC-LT population. Seven hundred and eighty-one adult patients transplanted between February 1, 1985 and June 30, 2016 were retrospectively analyzed. After propensity score match, 116 patients treated for ACR using steroid boluses were compared with …

Graft RejectionMaleTime Factorsmedicine.medical_treatmentLiver transplantationGastroenterologyAcute rejection; Liver biopsy; Liver transplantation; Recurrence; Steroid0302 clinical medicineRisk FactorsRecurrenceProspective cohort studyeducation.field_of_studymedicine.diagnostic_testIncidenceIncidence (epidemiology)Liver NeoplasmsGastroenterologyImmunosuppressionMiddle AgedLiver biopsyAllograftsEuropeTreatment Outcome030220 oncology & carcinogenesisLiver biopsyHepatocellular carcinomaAcute rejectionFemaleSteroids030211 gastroenterology & hepatologyImmunosuppressive Agentsmedicine.medical_specialtyCarcinoma HepatocellularPopulationRisk Assessment03 medical and health sciencesInternal medicinemedicineHumanseducationSteroidRetrospective StudiesLiver transplantationHepatologybusiness.industrymedicine.diseaseLiver TransplantationTransplantationNeoplasm Recurrence LocalbusinessHepatobiliary & Pancreatic Diseases International
researchProduct

Non-invasive Biomarkers of Acute Rejection in Kidney Transplantation: Novel Targets and Strategies

2019

Abstract: Kidney transplantation is considered the favored treatment for patients suffering from end-stage renal disease, since successful transplantation is associated with longer survival and improved quality of life compared to dialysis. Alloreactive immune responses against the donor kidney may lead to acute rejection of the transplant. The current diagnosis of renal allograft rejection mainly relies on clinical monitoring, including serum creatinine, proteinuria, and confirmation by histopathologic assessment in the kidney transplant biopsy. These parameters have their limitations. Identification and validation of biomarkers, which correlate with or predict the presence of acute reject…

0301 basic medicineOncologymedicine.medical_specialtymedicine.medical_treatmentMini Reviewnon-invasivekidney transplantationDisease030230 surgeryacute rejectioncell-free DNA03 medical and health scienceschemistry.chemical_compoundtranscriptomics0302 clinical medicineproteomicsInternal medicineBiopsymedicineDialysisKidney transplantationlcsh:R5-920CreatinineProteinuriamedicine.diagnostic_testbusiness.industrytransplant outcomeGeneral Medicinemedicine.diseaseTransplantation030104 developmental biologysurgical procedures operativechemistryBiomarker (medicine)MedicinebiomarkerHuman medicinemedicine.symptomlcsh:Medicine (General)business
researchProduct